Close Modal


October 22, 2020

Dr. Dvanajscak Takes the MYMP

resistant starch, Dvanajscak, MYMP, CKD, Arkana Laboratories

Dr. Dvanajsack was a part of a team of physicians who published a paper discussing how resistant starch (RS) improves CKD outcomes. In this report, the physicians study how RS modulates host‐microbiome interactions in CKD by measuring changes in the abundance of proteins and bacteria in the gut.

Read the Paper: Resistant Starch Slows the Progression of CKD in the 5/6 Nephrectomy Mouse Model

Who will take the MYMP next?